Danaher Profit Margin 2010-2024 | DHR

Current and historical gross margin, operating margin and net profit margin for Danaher (DHR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Danaher net profit margin as of December 31, 2024 is 16.33%.
Danaher Annual Profit Margins
Danaher Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Services $160.880B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.772B 12.00
Cencora (COR) United States $49.134B 18.48
Natera (NTRA) United States $23.357B 0.00
DiDi Global (DIDIY) China $22.601B 0.00
ICON (ICLR) Ireland $16.423B 14.63
Revvity (RVTY) United States $15.350B 25.74
Avantor (AVTR) United States $15.164B 22.74
BioMerieux (BMXMF) France $14.363B 0.00
Viatris (VTRS) United States $13.464B 4.15
CochLear (CHEOY) Australia $13.043B 0.00
Solventum (SOLV) United States $12.794B 0.00
Doximity (DOCS) United States $11.033B 64.94
Medpace Holdings (MEDP) United States $10.852B 30.57
EUROFINS SCIENT (ERFSF) Luxembourg $10.405B 0.00
HealthEquity (HQY) United States $9.569B 48.01
Charles River Laboratories (CRL) United States $8.425B 16.28
Sonic Healthcare (SKHHY) Australia $8.349B 0.00
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $6.114B 28.44
BrightSpring Health Services (BTSG) United States $4.109B 87.41
Organon (OGN) United States $4.007B 4.04
Sotera Health (SHC) United States $3.883B 20.77
Surgery Partners (SGRY) United States $3.240B 36.94
Concentras Parent (CON) United States $2.968B 0.00
Alignment Healthcare (ALHC) United States $2.950B 0.00
PACS (PACS) United States $2.214B 0.00
Premier (PINC) United States $2.178B 11.33
Ardent Health Partners (ARDT) United States $2.141B 0.00
GeneDx Holdings (WGS) United States $2.056B 0.00
Progyny (PGNY) United States $1.973B 39.95
GoodRx Holdings (GDRX) United States $1.818B 47.70
Teladoc Health (TDOC) United States $1.749B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Agilon Health (AGL) United States $1.376B 0.00
CareDx (CDNA) United States $1.250B 0.00
Pediatrix Medical (MD) United States $1.201B 11.75
AMN Healthcare Services Inc (AMN) United States $1.048B 7.09
Embecta (EMBC) United States $1.042B 7.29
Establishment Labs Holdings (ESTA) $0.897B 0.00
Auna S.A (AUNA) Luxembourg $0.639B 0.00
InnovAge Holding (INNV) United States $0.515B 0.00
SBC Medicals (SBC) United States $0.505B 0.00
DocGo (DCGO) United States $0.499B 18.81
Sonida Senior Living (SNDA) United States $0.440B 0.00
Enhabit (EHAB) United States $0.422B 36.52
QDM (QDMI) Hong Kong, SAR China $0.412B 0.00
MultiPlan (MPLN) United States $0.295B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.295B 0.00
Nutex Health (NUTX) United States $0.259B 0.00
LifeMD (LFMD) United States $0.241B 0.00
Sera Prognostics (SERA) United States $0.219B 0.00
Beauty Health (SKIN) United States $0.207B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Biodesix (BDSX) United States $0.150B 0.00
So-Young (SY) China $0.108B 18.32
Oncology Institute (TOI) United States $0.076B 0.00
Ascend Wellness Holdings (AAWH) United States $0.073B 0.00
IceCure Medical (ICCM) Israel $0.069B 0.00
NeueHealth (NEUE) United States $0.061B 1.60
ModivCare (MODV) United States $0.057B 3.10
Singular Genomics Systems (OMIC) United States $0.050B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
OncoCyte (OCX) United States $0.035B 0.00
Co-Diagnostics (CODX) United States $0.024B 0.00
Pheton Holdings (PTHL) China $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
KindlyMD (KDLY) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.007B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.000B 0.00
Cano Health (CANOQ) United States $0.000B 0.00